Keya Medical

AI for Smarter Healthcare

Keya Medical Series D Funding

Keya Medical Raises $46M in Series D Round.


Keya Medical is a medical technology manufacturer developing AI solutions that enable healthcare delivery organizations to provide better patient care.

Since 2016, the company has combined advanced deep learning algorithms with other technologies to provide accurate diagnosis and treatment solutions to medical institutions around the world.

Today, Keya Medical has partnered with over 200 healthcare systems around the world, and the company’s products are used widely in hospitals throughout Asia.

DeepVessel FFR

DeepVessel FFR* uses deep learning technology to perform a non-invasive physiological functional assessment of the coronary arteries using coronary CT angiogram scans. The software reduces unnecessary invasive testing to lower costs and complications.

*CE Marked, National Medical Products Administration (NMPA) Approved. Not for sale in the United States.

DeepVessel Certification 2020

DeepVessel FFR Approved for Clinical Use in China

On January 15, 2020, the National Medical Products Administration (NMPA) in China issued the registration certificate approving DeepVessel FFR for clinical use.

CuraRad® – ICH

Deep Learning triage of suspected intracranial hemorrhage in CT scans
*510(k) cleared by the U.S. Food & Drug Administration

Who do we work with

Healthcare Delivery

Keya Medical is committed to developing medical imaging AI solutions in collaboration with healthcare providers. Since 2016, we have worked with more than 200 hospitals around the world.


Keya Medical is continuing to develop new solutions to improve cardiovascular disease diagnosis and treatment. We invite payers to continue the conversation on how our solutions can create savings.


Keya Medical is funded by visionary investors who want to make a positive social impact and benefit from the potential expansion of medical AI.

Latest News

Start a collaboration with Keya Medical